Inside Health Reform
CMS' new guidance on keeping the ACA risk corridor program budget neutral is a mixed bag for plans but provides a ray of hope that insurers will be made whole for payments in 2016, sources tell Inside Health Policy.
Featured Story: Eyes On HHS For More Details On The 8 Million Sign-Ups
The White House announced that 8 million people chose plans on the exchanges by April 15, but more details are on the way because HHS has yet to release key demographic information on those enrollees and a breakdown of all the states' figures.
It will be difficult to replace CMS Principal Deputy Administrator Jon Blum with someone as steeped in both the details and politics of Medicare policy, Republican and Democratic lobbyists and consultants said Tuesday (April 22) upon learning Blum will leave the agency.
A group of House Energy and Commerce Committee Republicans said they stand ready to talk with FDA about alternative approaches to the agency's controversial proposed generic drug labeling rule, according to a letter sent Tuesday (April 22) to FDA Commissioner Margaret Hamburg.
The country's largest Catholic and non-profit health system pledged $1 million to Enroll America following a March 2013 call between HHS Secretary Kathleen Sebelius and Ascension Health's CEO that focused on educating consumers about new coverage options made possible by the ACA, a new Government Accountability Office report reveals.
The nation's largest insurer during its 2014 first quarter earnings call suggested it will be moving into more public exchanges in the coming year but also noted that it continues to face headwinds due to the Affordable Care Act's insurance tax, sequestration and rate cuts to Medicare Advantage.
The Pew Charitable Trust's bid to get FDA-mandated Unique Device Identifiers incorporated into insurance claims forms has been bolstered by several stakeholders that foresee benefits, like enabling the inclusion of medical devices in FDA's Sentinel postmarket surveillance system.
Supreme Court justices challenged Coca-Cola's argument Monday (April 21) that Congress intended for FDA's authority to preempt mislabeling claims brought under the Lanham Act, saying the nutrition labeling law's preemption of state laws does not directly imply federal preemption and a label that gets through FDA could still be misleading.
Inpatient psychiatric facilities' quality measures will be posted on the "Hospital Compare" website for the first time, though quality measures on patients discharged on multiple antispsychotics medications won't become public until next year due to unexpected technical issues.
About This Site
InsideHealthPolicy.com is a subscription-based news service. Access requires a subscription to one or more of our three areas of coverage (listed below), each of which includes both online and print components.
New: Health Exchange Alert - Daily news and analysis on the hottest issue in health care reform – federal and state requirements for the creation of health insurance exchanges.
Inside CMS - Covering Medicare and Medicaid from the inside out.
FDA Week - Exclusive reporting on the Food and Drug Administration's regulation of drugs, devices, food safety and related areas.
Sign up for one month of free, no-obligation access to InsideHealthPolicy.com.
Health Reform Insider
Stakeholders are digesting updated Congressional Budget Office scores that show the cost of fixing the flawed Medicare physician pay formula is creeping back up and the savings linked to many of the likely offsets are shifting, signaling the task may become more difficult if lawmakers resume efforts to replace the flawed Sustainable Growth Rate formula next year.
Drug Pricing Debate
Medicaid health plans are readying a public push to voice their worries about new, costly Hepatitis C medications that have recently come onto the market and plan to send a letter to state Medicaid directors this week about developing solutions so that plans and the program remain financially solvent, the head of Medicaid Health Plans of America tells Inside Health Policy.